
Reset all filters
01 1Alcon Canada Inc.
02 2BGP Pharma ULC
Reset all filters
01 12414737
02 12468958
03 12570976
Reset all filters
01 3Tobramycin
Reset all filters
01 2Capsule
02 1Solution
Reset all filters
01 12021-06-26
02 12022-12-19
03 12025-06-20
Patent Expiration Date : 2021-06-26
Date Granted : 2009-01-06
Brand Name : TOBRAMYCIN
Patent Number : 2414737
Filing Date : 2001-06-26
Strength per Unit : 0.3%
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Ophthalmic
Patent Expiration Date : 2021-06-26
Date Granted : 2009-01-06
Patent Expiration Date : 2025-06-20
Date Granted : 2013-08-13
Brand Name : TOBI PODHALER
Patent Number : 2570976
Filing Date : 2005-06-20
Strength per Unit : 28 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral Inhalation
Patent Expiration Date : 2025-06-20
Date Granted : 2013-08-13
Patent Expiration Date : 2022-12-19
Date Granted : 2012-07-03
Brand Name : TOBI PODHALER
Patent Number : 2468958
Filing Date : 2002-12-19
Strength per Unit : 28 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral Inhalation
Patent Expiration Date : 2022-12-19
Date Granted : 2012-07-03